ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,780Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 680

$1.73M Total Retail Price of All Prescriptions

Rank: 11 out of 680

817 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 817 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 817 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 25,892 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 1,054 958 1 2
FUROSEMIDE 1,013 960 2 6
AMLODIPINE BESYLATE 768 697 3 1
LISINOPRIL 755 690 4 5
SIMVASTATIN 637 595 5 3
OMEPRAZOLE 525 475 6 7
DONEPEZIL HCL 514 511 7 27
HYDROCODONE-ACETAMINOPHEN 509 420 S3 8 4
NAMENDA 508 508 9 35
METOPROLOL TARTRATE 453 424 10 12
PANTOPRAZOLE SODIUM 425 406 11 30
WARFARIN SODIUM 417 336 12 20
CITALOPRAM HBR 381 339 13 22
POTASSIUM CHLORIDE 372 372 14 14
ATORVASTATIN CALCIUM 371 327 15 11
METFORMIN HCL 362 331 16 8
CARVEDILOL 342 311 17 23
GABAPENTIN 335 273 18 15
METOPROLOL SUCCINATE 331 311 19 13
PRAVASTATIN SODIUM 328 270 20 10
VENLAFAXINE HCL ER 306 282 21 101
CYMBALTA 294 254 22 46
QUETIAPINE FUMARATE 291 287 23 64
CLOPIDOGREL 280 278 24 26
ISOSORBIDE MONONITRATE ER 267 267 25 59
LOSARTAN POTASSIUM 263 232 26 21
ESCITALOPRAM OXALATE 252 223 27 45
LACTULOSE 243 236 28 92
HYDROCHLOROTHIAZIDE 243 226 28 9
SERTRALINE HCL 220 220 30 28
BENAZEPRIL HCL 218 195 31 40
POLYETHYLENE GLYCOL 3350 213 203 32 62
TRAMADOL HCL 211 205 33 18
NEXIUM 210 159 34 16
FENOFIBRATE 205 158 35 66
RANITIDINE HCL 204 177 36 56
DIVALPROEX SODIUM 202 189 37 110
ALLOPURINOL 201 201 38 33
ATENOLOL 200 186 39 19
TAMSULOSIN HCL 198 186 40 34
GLIMEPIRIDE 197 169 41 29
CIPROFLOXACIN HCL 189 156 42 57
FLUTICASONE PROPIONATE 186 140 43 41
PLAVIX 184 183 44 39
TRAZODONE HCL 173 157 45 48
DIOVAN 168 159 46 31
LANTUS 167 146 47 49
MIRTAZAPINE 165 154 48 78
OXYBUTYNIN CHLORIDE 155 145 49 129
RISPERIDONE 154 154 50 80
ADVAIR DISKUS 147 128 51 53
MEGESTROL ACETATE 147 147 R 51 88
SEROQUEL 144 144 53 123
FAMOTIDINE 137 129 54 89
SPIRONOLACTONE 133 109 55 82
CRESTOR 131 97 56 25
DIGOXIN 130 113 57 58
MELOXICAM 128 98 58 24
JANUVIA 123 119 59 60
METHYLPREDNISOLONE 121 94 60 93
ALENDRONATE SODIUM 118 109 61 32
NOVOLIN N 117 104 62 225
ALBUTEROL SULFATE 117 94 62 154
ZOLPIDEM TARTRATE 116 82 64 17
ABILIFY 111 93 65 178
AZITHROMYCIN 109 96 66 42
PAROXETINE HCL 107 89 67 76
NOVOLOG FLEXPEN 107 105 67 189
ALPRAZOLAM 107 87 67 72
AMIODARONE HCL 107 106 67 158
TRIAMTERENE-HCTZ 105 100 71 52
RIVASTIGMINE 104 104 72 309
SUCRALFATE 101 85 73 160
CLONIDINE HCL 98 95 74 36
RAMIPRIL 98 84 74 69
GLIPIZIDE 97 97 76 63
PREDNISONE 97 83 76 50
LANTUS SOLOSTAR 96 91 78 84
MUPIROCIN 95 80 79 130
AMOX TR-POTASSIUM CLAVULANATE 94 88 80 124
DILTIAZEM 24HR CD 92 85 81 182
CARBIDOPA-LEVODOPA 92 92 81 117
ENABLEX 91 80 83 217
LOVASTATIN 88 85 84 44
TRICOR 87 66 85 98
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 83 85 94
SPIRIVA 86 68 87 70
FINASTERIDE 86 84 87 109
NOVOLIN R 86 74 87 113
NOVOFINE AUTOCOVER 83 83 90 248
DIVALPROEX SODIUM ER 82 70 91 148
MECLIZINE HCL 79 79 92 103
OLANZAPINE 76 76 93 116
CLONAZEPAM 75 63 94 190
LYRICA 72 68 95 77
LEVEMIR FLEXPEN 70 70 96 186
AMITRIPTYLINE HCL 69 64 R 97 47
SYNTHROID 68 68 98 38
FENTANYL 68 68 S2 98 183
QUINAPRIL HCL 68 68 98 104
LEXAPRO 67 61 101 128
ONGLYZA 65 64 102 136
EXELON 64 64 103 112
BUPROPION XL 62 46 104 161
TRIAMCINOLONE ACETONIDE 61 55 105 199
SOTALOL 61 53 105 226
LIPITOR 59 59 107 68
IRBESARTAN 59 57 107 247
BUSPIRONE HCL 58 46 109 144
DILTIAZEM ER 58 53 109 165
VERAPAMIL ER 58 58 109 100
ENOXAPARIN SODIUM 58 57 109 260
PROAIR HFA 56 35 113 67
DOXYCYCLINE HYCLATE 56 46 113 95
GLYBURIDE 55 36 R 115 85
IPRATROPIUM BROMIDE 55 55 115 211
PRIMIDONE 55 55 115 382
KLOR-CON M10 55 43 115 127
DILTIAZEM 24HR ER 55 44 115 132
PROPRANOLOL HCL 54 43 120 145
FLUOXETINE HCL 53 50 121 74
AMLODIPINE BESYLATE-BENAZEPRIL 52 42 122 43
DETROL LA 51 44 123 169
DOXAZOSIN MESYLATE 51 51 123 73
CYCLOBENZAPRINE HCL 51 50 R 123 81
TIMOLOL MALEATE 51 50 123 337
LORAZEPAM 50 45 127 125
NYSTATIN 50 46 127 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.